SANCUSO Transdermal patch Ref.[8214] Active ingredients: Granisetron

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: Kyowa Kirin Holdings B.V., Bloemlaan 2, 2132NP Hoofddorp, The Netherlands, Tel: +31 (0) 237200822

Product name and form

SANCUSO 3.1 mg/24 hours transdermal patch.

Pharmaceutical Form

Transdermal patch.

Thin, translucent, matrix-type, rectangular-shaped transdermal patch with rounded corners.

Qualitative and quantitative composition

Each 52 cm² transdermal patch contains 34.3 mg of granisetron releasing 3.1 mg of granisetron per 24 hours.

For the full list of excipients, see section 6.1.

Active Ingredient Description

Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy.

List of Excipients

Backing layer: Polyester

Matrix layer: Acrylate-vinylacetate copolymer

Release liner: Siliconised polyester

Pack sizes and marketing

Each transdermal patch is packaged in a heat-sealed sachet composed of polyester-coated paper/aluminium/LLDPE.

Each carton contains 1 transdermal patch.

Marketing authorization holder

Kyowa Kirin Holdings B.V., Bloemlaan 2, 2132NP Hoofddorp, The Netherlands, Tel: +31 (0) 237200822

Marketing authorization dates and numbers


Date of first authorisation: 20 April 2012
Date of latest renewal: 9 January 2017


Drug Countries
SANCUSO Austria, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.